alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.7



 Exhibit 10.7 
 FIFTH AMENDMENT TO PURCHASE CONTRACT 
 THIS FIFTH AMENDMENT TO PURCHASE
CONTRACT (“FIFTH Amendment”) is made effective as of October 12, 2012, by and between TWIN CITY CROSSING, LLC, (“Seller”) and WHEELER INTERESTS, INC. (“Purchaser”). 

RECITALS: 

Whereas, Seller and Purchaser previously entered into that certain Purchase Contract, dated June 11, 2012, as amended by First
Amendment to Purchase Contract, dated July 26, 2012, as further amended by Second Amendment to Purchase Contract, dated August 9, 2012, as further amended by Third Amendment to Purchase Contract, dated August 16, 2012, as further
amended by Fourth Amendment to Purchase Contract, dated August 30, 2012 (as amended, the “Agreement”) for the sale of the Property as defined in the Agreement, including, without limitation, certain real property and improvements
located in the Town of Batesburg-Leesville, County of Lexington, South Carolina; 
 WHEREAS, Purchaser and Seller desire to
amend the Agreement as set forth herein; 
 NOW, THEREFORE, in consideration of the premises and other good and valuable
consideration, the receipt of which is hereby acknowledged, Purchaser and Seller hereby undertake and agree as follows: 
 1.
Defined Terms. Terms defined in the Agreement shall have the same meanings in this FIFTH Amendment unless specifically codified herein. 
 2. Closing Date. The Closing Date shall be on or before November 9, 2012. 
 3. Execution by Facsimile/Counterparts. Execution of this instrument may be evidenced by facsimile signature which shall be deemed an original for all purposes. To facilitate execution, this FIFTH
Amendment may be executed in as many counterparts as may be required; and it shall not be necessary that the signature of, or on behalf of, each party, or that the signatures of the persons required to bind any party, appear on one or more such
counterparts. All counterparts shall collectively constitute a single agreement. 
 4. Agreement Remains in Effect.
Subject to the specific amendments and agreements set forth in this FIFTH Amendment, the Agreement shall remain in full force and effect without modification. 
 [SIGNATURES ON FOLLOWING PAGE] 







 IN WITNESS WHEREOF, Seller and Purchaser have caused this FIFTH Amendment to be signed as of
the date first above written. 
  

									
	SELLER:	 		 	TWIN CITY CROSSING, LLC, a Georgia limited liability company
			
		 		 	By: Du Rhone Group, Ltd., its Manager
					
		 		 		 	By:	 	 /s/ Neil R. Smith

		 		 		 	Neil R. Smith
		 		 		 	Executive Vice President
			
	PURCHASER:	 		 	WHEELER INTERESTS, INC.
				
		 		 	By:	 	 /s/ Jon S. Wheeler

		 		 	Name:	 	 JON S. WHEELER

		 		 	Its:	 	 PRESIDENT/CEO
No. 63769.

protest 58/10161 (Los Angeles).

#### Frank P. Dow Co., Inc., of L.A. and Sterling Liquor Distributors, Inc. *v.*United States,

Opinion by

Johnson, J.

It was stipulated that the facts and issues herein are similar in all material respects to those involved in *United States*v. *Browne Vintners Co., Inc.*(34 C.C.P.A. 112, C.A.D. 351) and that the quantities reported! *333by the inspector as manifested, not found, were not in fact received by the importers. In accordance with stipulation of counsel and following the decision cited, it was held that duty and internal revenue tax are not assessable upon such portions of the merchandise as were reported by the inspector as manifested, not found. The protest was sustained to this extent.
Summary of Selenium Analyzer Contact Information

Prepared July 28, 2015

Question PS Analytical Aqua Metrology Systems 

(AMS)

Product Online Model (10.255)

Laboratory Model (10.055)

SafeGuard IIITM (w/ preprocessor)

Has the analyzer been used to 

test FGD wastewater (including 

other countries?) What type of 

tests, how many locations, 

duration of test.

Yes, trials of the online model 

with Southern Company, one 

plant; 10 locations at the plant; 

3-month trial.

Used unit to test European 

power plant samples.

Yes, long-term trials at Duke 

(IN), and Southern Research. 

Currently sending out 4 units for 

tests (Water Research Center, 

American Electric Power, EPRI)

Is the analyzer used for other 

types of industrial wastewater?

Yes, refinery wastewaters Yes, mining and drinking water 

applications

How does the analyzer work? UV oxidation hydride 

generation atomic fluorescence 

spectrometry

Pre-processor: mineralize, 

oxidize, reduce sample followed 

by cathodic stripping 

voltammetry

How are samples collected (online, continuous or intermittent)Online (pulls sample 

automatically for analysis –

intermittent)

Online (pulls sample 

automatically for analysis –

intermittent)

How do results compare to ICPMS results for total selenium? 

What data are available?

Good comparison

See telecom for data available

Good comparison (+/- 10%)

See telecom for data available

Can different forms of selenium 

be quantified?

Yes, there is selenium speciation 

module that can be purchased 

and used

Technology measures selenite 

(so the preprocessor converts all 

selenium to that oxidation state 

for measurement)

What is the measurement range 

for selenium?

20 ppt – low ppm levels 5 ppb – several thousand ppb

What are constraints for the 

wastewater (TDS limits or other 

constituents)?

No constraints No constraints

Why aren’t plants using these 

analyzers now?

Not required, but are seeing 

requests with ELG regs.

Not required, but are seeing 

requests with ELG regs.

What are the costs (capital, 

operating, total annual cost –

based on what frequency of 

analysis)?

Online unit:

Capital: $70,000

Annual: $12,800

Laboratory unit:

Capital: $28,000

Annual: to be provided 

Online unit:

Capital: $50,000

Annual: $5,950

What is done with the residuals 

from the analysis?

Discharge or looped to start of 

treatment flow

Discharge or recycle into the 

treatment system

What training is required to be 

able to use the analyzer?

Online unit – one week for 

installation, testing, and training

Laboratory unit – 1 day of 

training

Online unit – 1-2 days for 

installation, testing, and training
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE OPTEL,
INC THREE MONTH PERIOD ENDED NOVEMBER 30, 1997 FINANCIAL STATEMENTS AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          AUG-31-1998
<PERIOD-END>                               NOV-30-1997
<CASH>                                          30,231
<SECURITIES>                                         0
<RECEIVABLES>                                    5,978
<ALLOWANCES>                                    (1,221)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                         203,696
<DEPRECIATION>                                 (18,298)
<TOTAL-ASSETS>                                 399,161
<CURRENT-LIABILITIES>                                0
<BONDS>                                        356,850
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            26
<OTHER-SE>                                       4,069
<TOTAL-LIABILITY-AND-EQUITY>                   399,161
<SALES>                                              0
<TOTAL-REVENUES>                                12,252
<CGS>                                                0
<TOTAL-COSTS>                                    5,765
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              11,744
<INCOME-PRETAX>                                (16,270)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (16,270)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (16,270)
<EPS-PRIMARY>                                    (6.31)
<EPS-DILUTED>                                    (2.77)
        

</TABLE>
EXHIBIT 99.6








CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT





In connection with the annual report of TransGlobe Energy Corporation (the “Registrant”) on Form 40-F for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ross G. Clarkson, Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





|   |                                                                                                                                  
|-- | ---------------------------------------------------------------------------------------------------------------------------------
|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and




|   |                                                                                                                                                        
|-- | -------------------------------------------------------------------------------------------------------------------------------------------------------
|2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.



















/s/    Ross G. Clarkson


Name: Ross G. Clarkson


Title:  Chief Executive Officer


March 7, 2018
From: bry.shields@gmail.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:59:47 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Bry Shields

Mobile, AL 36606
From: dianebaumgart@sbcglobal.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:38:24 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Diane Baumgart

Kaukauna, WI 54130
Search all of Utah.gov » Skip to Main Content

Advisories 1. Health Risks 2. Map 3. FAQ 4. Resources 5. Contacts 6.

The Environmental Epidemiology Program (EEP) completed a health consultation recommending that a consumption advisory for wate rfowl harvested from the Great Salt Lake ma rshes be issued because of the elevated levels of mercury detected. Common Goldeneye

Adults should eat no more than one 8-ounce meal per month, and children, pregnant women and women who may become pregnant should not eat Common Goldeneye from Great Salt Lake marshes.

Cinnamon Teal Utah Waterfowl Advisories - Consumption Advisori es http://waterfowladvisories.utah.gov/advisories.htm

1 of 3 10/18/2012 3:24 PMAdults should eat no more than two 8-ounce meals per month, and children, pregnant women and women who may become pregnant should eat no more than one 4-ounce meal per month of Cinnamon Teal from Great Salt Lake marshes.

Northern Shoveler

Adults should eat no more than two 8-ounce meals per month, and children, pregnant women and women who may become pregnant should eat no more than one 4-ounce m eal per month of Northern Shoveler from Great Salt Lake marshes. This web site sponsored by:

Photographs by: Tom Grey Advisories 1. Health Risks 2. Utah Waterfowl Advisories - Consumption Advisori es http://waterfowladvisories.utah.gov/advisories.htm

2 of 3 10/18/2012 3:24 PMMap 3. FAQ 4. Resources 5. Contacts 6. Top 7. Utah.gov Home | Utah.gov Terms of Use | Utah.gov Privacy Policy | Utah.gov Accessibility Policy | Translate Utah.gov Copyright © 2012 State of Utah - All rights reserved. Utah Waterfowl Advisories - Consumption Advisori es http://waterfowladvisories.utah.gov/advisories.htm

3 of 3 10/18/2012 3:24 PM
From: suemcclurelpc@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:16:15 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Suzanne McClure

Saint Louis, MO 63119
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Transportation

###### Federal Highway Administration

          - [Docket No. FHWA-2023-0026]

# AGENCY:

Federal Highway Administration (FHWA), Department of Transportation (DOT).

# ACTION:

Notice; withdrawal.

# SUMMARY:

                        The FHWA is withdrawing the notice, “Agency Information Collection Activities: Request for Comments for a New Information Collection,” published in the                         **Federal Register**                         on September 15, 2023.                    

# FOR FURTHER INFORMATION CONTACT:

Jason Broehm, Office of Safety, 202-366-2201, Federal Highway Administration, Department of Transportation, 1200 New Jersey Avenue SE, Washington, DC 20590. Office hours are from 9 a.m. to 5:30 p.m., from Monday through Friday, except Federal holidays.

# SUPPLEMENTARY INFORMATION:

                    The FHWA is withdrawing the notice published in the                     **Federal Register**                     on September 15, 2023, at 88 FR 63643 (FR Doc. 2023-20042).                

Issued on: September 15, 2023.

Jazmyne Lewis,

Information Collection Officer. 

[FR Doc. 2023-20341 Filed 9-19-23; 8:45 am]

BILLING CODE 4910-22-P
Before the Second Division,

January 30, 1961

No. 65109.

#### Gamble-Vargish & Co., DBA Seabury & Co., et al. *v.*United States,

protests 59/17968, etc. (Los Angeles).

Opinion by

Ford, J.

In accordance with stipulation of counsel that the merchandise consists of pigtails similar in all material respects to those the subject of Abstract 63984, the claim of the plaintiffs was sustained.
#### Brooklyn Mason Contracting Company, Respondent, *v.*May Berger, Appellant, and Keshin Blitstein & Company, Respondent.

*Brooklyn Mason Contracting Co.*v. Berger, 144 App. Div. 908, affirmed.

(Argued December 12, 1912;

decided December 31, 1912.)

Appeal from a judgment of the Appellate Division of the Supreme Court in the second judicial department, entered April 27, 1911, affirming a judgment in favor of plaintiff entered upon the report of a referee in an action to foreclose a mechanic’s lien.

*J. Brownson Ker*and *Stephen Frontera*for appellant.

*Abraham Levitt*for respondent.

Judgment affirmed, with costs; no opinion.

Concur: Cullen, Ch. J., Gray, Werner, Willard Bartlett, Hiscock, Chase and Collin, JJ.
```

[114th Congress Public Law 146]
[From the U.S. Government Publishing Office]

[[Page 130 STAT. 357]]

Public Law 114-146
114th Congress

                                 An Act

 
 To expand the tropical disease product priority review voucher program 
  to encourage treatments for Zika virus. <<NOTE: Apr. 19, 2016 -  [S. 
                                2512]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled, <<NOTE: Adding Zika 
Virus to the FDA Priority Review Voucher Program Act.>> 
SECTION 1. <<NOTE: 21 USC 301 note.>>  SHORT TITLE.

    This Act may be cited as the ``Adding Zika Virus to the FDA Priority 
Review Voucher Program Act''.
SEC. 2. EXPANDING TROPICAL DISEASE PRODUCT PRIORITY REVIEW VOUCHER 
                    PROGRAM TO ENCOURAGE TREATMENTS FOR ZIKA VIRUS 
                    DISEASE.

    Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360n(a)(3)) is amended--
            (1) by redesignating subparagraph (R) as subparagraph (S);
            (2) in subparagraph (Q), by striking ``Filoviruses'' and 
        inserting ``Filovirus Diseases''; and
            (3) by inserting after subparagraph (Q) the following:
                    ``(R) Zika Virus Disease.''.

    Approved April 19, 2016.

LEGISLATIVE HISTORY--S. 2512:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 162 (2016):
            Mar. 17, considered and passed Senate.
            Apr. 12, considered and passed House.

                                  <all>
```